118 related articles for article (PubMed ID: 15185321)
1. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Loria P; Lonardo A; Carulli N
Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
[No Abstract] [Full Text] [Related]
2. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.
Valenti L; Dongiovanni P; Fracanzani AL; Santorelli G; Fatta E; Bertelli C; Taioli E; Fiorelli G; Fargion S
Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071
[TBL] [Abstract][Full Text] [Related]
4. Nash, insulin resistance and iron.
Machado M; Cortez-Pinto H
Liver Int; 2006 Dec; 26(10):1159-62. PubMed ID: 17105580
[No Abstract] [Full Text] [Related]
5. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?
Bhattacharya R; Kowdley KV
Gastroenterology; 2003 Aug; 125(2):615-6; discussion 617. PubMed ID: 12891567
[No Abstract] [Full Text] [Related]
6. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.
Duseja A; Das R; Nanda M; Das A; Garewal G; Chawla Y
World J Gastroenterol; 2005 Jan; 11(3):393-5. PubMed ID: 15637751
[TBL] [Abstract][Full Text] [Related]
8. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
[No Abstract] [Full Text] [Related]
9. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
[TBL] [Abstract][Full Text] [Related]
10. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
11. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
García Buey L; González Mateos F
Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
[No Abstract] [Full Text] [Related]
12. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload.
Fargion S; Valenti L; Fracanzani AL
Hepatology; 2010 Apr; 51(4):1119-21. PubMed ID: 20373367
[No Abstract] [Full Text] [Related]
13. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
Raszeja-Wyszomirska J; Kurzawski G; Lawniczak M; Miezynska-Kurtycz J; Lubinski J
World J Gastroenterol; 2010 May; 16(20):2531-6. PubMed ID: 20503453
[TBL] [Abstract][Full Text] [Related]
15. [Iron in the era of molecular biology].
Deugnier Y; Moirand R; Brissot P; David V
Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
[TBL] [Abstract][Full Text] [Related]
16. HFE mutations in insulin resistance-associated hepatic iron overload.
Guillygomarc'h A; Mendler MH; Moirand R; Jouanolle AM; David V; Deugnier Y
J Hepatol; 2000 Sep; 33(3):515-6. PubMed ID: 11020014
[No Abstract] [Full Text] [Related]
17. Iron as a co-morbid factor in nonhemochromatotic liver disease.
Bonkovsky HL; Lambrecht RW; Shan Y
Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298
[TBL] [Abstract][Full Text] [Related]
18. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
19. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation.
Brandhagen DJ; Alvarez W; Therneau TM; Kruckeberg KE; Thibodeau SN; Ludwig J; Porayko MK
Hepatology; 2000 Feb; 31(2):456-60. PubMed ID: 10655270
[TBL] [Abstract][Full Text] [Related]
20. [Involvement and role of iron in nonalcoholic steatohepatitis].
Cojocariu C; Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
